Milan, June 6, 2024 – BetaGlue™ Therapeutics (“BetaGlue” or the “Company”) a clinical-stage radiotherapy company developing novel products for the personalised treatment of solid tumour cancers today announces the closing of an €8m equity financing round. The round included both existing and new investors and was led by Neva SGR S.p.A.,
"Among its strengths are its revolutionary, protected and patented technology enabling applications and trends in diverse and growing sectors, its solid corporate structure including top industry partners, and a business model that is extremely scalable thanks to royalties." The company The company was founded in 2017 as a spin-off from
Olympic athletes Sofia Goggia and Elena Curtoni underwent the regenerative knee cartilage treatment developed by our portfolio start-up LIPOGEMS, which will enable them to regenerate and heal tissues damaged during the last competitive season in just a few months. LIPOGEMS, which enjoys the status of an innovative SME, has developed a Made in
PICOSATS, a spin-off company of the University of Trieste founded by Professor Anna Gregorio in 2014 and established at the Area Science Park, announced that it has signed a contract with the space logistics transport company D-Orbit for the in-orbit demonstration of the RADIOSAT transceiver and BEAMSAT antenna. The mission
“The real backbone of the internet, what guarantees its functioning, is made up of physical cables, very long and very thick: their total length is 32 times the circumference of the earth”. The indispensability of submarine connections When speaking of communication infrastructures, one often imagines high-impact networks, all over
Alessandro Vairelli, CEO of Microchannel Devices (MCD), has completed the path that led his idea to become a reality in a few years, despite the difficulties and slowdowns experienced in the last two years due to the well-known external factors-pandemic first and war later-that are affecting the global economy. The
1000 Pharmacies unveils new brand identity 1000 Pharmacies, the startup in the LIFTT portfolio launched in September 2020 by Nicolò Petrone, together with his two co-founders Mohamed Younes and Alberto Marchetti, was created to offer a simpler online pharmacy experience that could be used by millions of people. The mission
Arthrosis, a disease that is constantly increasing and has a high social cost.Osteoarthritis (OA) is one of the most common chronic diseases and underestimated by those who do not suffer from it, characterised by intense pain with little tendency to resolve and consequent reduced mobility. Osteoarthritis (OA) affects about 250
LIFTT invests EUR 3 million in clean nuclear start-up founded by our President Stefano Buono, which expands in France.The dramatic combination of the climate emergency and the geopolitical crisis we are currently experiencing has demonstrated, if proof were still needed, the irreversible urgency to definitively eliminate dependence on fossil fuels
Paola Allamano, co-founder and CEO of WaterView, announces the start of the strategic partnership with Autostrade per l’Italia: “We have defined,” she explains, “a framework contract that consists of several aspects, primarily the collaboration we will offer for weather monitoring using existing camera circuits. Autostrade will expand this scope by
VAT n. 12013790014
Shared Capital
€ 100.835.954,00 authorised,
€ 43.482.552,00 paid,
€ 40.000.000,00 as per last statutory financial statements.
LIFTT S.p.A. adopts an Organization, Management and Control Model in line with the provisions of Legislative Decree 231/2001, and the Code of Ethics as completing part of the Model.